相关实验视频
Updated: May 21, 2025

10:42
Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
17.0K
在美国人口中,口腔微生物群多样性与慢性阻塞性肺病之间的关联
Xian-Xin Xia1, Chuan-Xiang Li1, Hong-Rong Guo2
1Department of Respiratory and Critical Care Medicine, The Third Hospital of Wuhan, Wuhan, 430030, People's Republic of China.
Journal of translational medicine
|May 17, 2025
概括
较低的口腔微生物群多样性与慢性阻塞性肺病 (COPD) 风险增加有关. 这项研究发现,COPD患者和没有COPD患者之间的口腔微生物群落存在显著差异.
科学领域:
- 微生物组研究的研究.
- 肺部医学 肺部医学
- 基因组学就是基因组学.
背景情况:
- 关于口腔微生物群多样性和COPD风险的基于人口的研究很少.
- 了解这种关系对于识别COPD潜在生物标志物和治疗点至关重要.
研究的目的:
- 调查口腔微生物群多样性 (α和β多样性) 与慢性阻塞性肺病 (COPD) 风险之间的关联.
主要方法:
- 来自国家健康和营养检查调查 (NHANES 2009-2012) 的截面数据的分析.
- 利用多变量后勤回归和限制立方线来评估α多样性和COPD风险.
- 采用主要坐标分析 (PCoA) 和变多变量变异分析 (PERMANOVA) 来分析COPD和非COPD组之间的β多样性差异.
主要成果:
- 总共有6061名参与者被纳入.
- 阿尔法多样性指标 (观察到的ASV,Faith的家族遗传多样性,Shannon-Weiner指数) 与COPD风险有显著的负相关性.
- 贝塔多样性分析显示,COPD和非COPD组之间的微生物社区结构 (Bray-Curtis,未加权和加权的UniFrac距离) 在统计学上有显著差异 (P <0.01).
结论:
- 在患有和没有COPD的个体之间,口腔微生物群的α和β多样性存在显著差异.
- 减少口腔微生物群多样性与COPD风险有负面关联,这表明它可能在疾病发展中起作用.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Other Pulmonary Disorders
789
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
789

